0GP7 Medivir AB (publ)

Partial data

LSE · GB · Healthcare · Biotechnology · medivir.com

1.718SEK-1.26%Mkt Cap: —P/E: —24d ago

Medivir AB (publ), a pharmaceutical company, focuses on the development and commercialization of medical treatments in areas of high unmet medical need in Sweden, the Nordic region, the rest of Europe, and internationall…

Industry Peers

Biotechnology

Screen all

VRTX

Vertex Pharmaceuticals Incorporated - Common Stock

$129.20BUSDP/E 29.7

MRNA

Moderna, Inc. - Common Stock

$89.83BUSD

REGN

Regeneron Pharmaceuticals, Inc. - Common Stock

$76.86BUSDP/E 18.5

ARGX

argenx SE - American Depositary Shares

Revolution Medicines, Inc. - Common Stock

$40.67BUSD

ONC

BeOne Medicines Ltd. - American Depositary Shares

$40.33BUSDP/E 63.4

RPRX

Royalty Pharma plc - Class A Ordinary Shares

$32.90BUSDP/E 30.3

ALNY

Alnylam Pharmaceuticals, Inc. - Common Stock

$31.13BUSDP/E 39.2

ROIV

Roivant Sciences Ltd. - Common Shares

$25.60BUSD

BNTX

BioNTech SE - American Depositary Shares

$24.36BUSD

INCY

Incyte Corporation - Common Stock

$22.86BUSDP/E 14.4

GMAB

Genmab A/S - American Depositary Shares

Insmed Incorporated - Common Stock

$21.97BUSD

ASND

Ascendis Pharma A/S - Ordinary Share

$15.08BUSDP/E 17.6

EXEL

Exelixis, Inc. - Common Stock

$14.83BUSDP/E 18.9

JAZZ

Jazz Pharmaceuticals plc - Ordinary Shares

$14.18BUSDP/E 15.0

SMMT

Summit Therapeutics Inc. - Common Stock

$14.03BUSD

Key Statistics

Company

Market Cap—

Enterprise Value77.73M USD

Revenue (TTM)832.75K USD

Gross Profit-3.05M USD

Net Income (TTM)-8.35M USD

Revenue/Share0.03 SEK

Last Price1.718 SEK

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees6

CountryGB

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-9.31

EV/Revenue93.34

P/S—

P/B3.59

EPS (TTM)-1.58

EPS (Forward)—

52W Range

0.403519% of range7.350

52W High7.350 SEK

52W Low0.4035 SEK

Profitability

Gross Margin0.00%

Oper. Margin-1766.67%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-46.51%

ROA-22.63%

Growth

Revenue Growth-20.00%

Earnings Growth—

Cash Flow & Leverage

Operating CF-4.94M USD

CapEx (TTM)—

FCF Margin-971.34%

FCF Yield—

Net Debt-23.82M USD

Net Debt/EBITDA2.85

Balance Sheet

Debt/Equity1.52

Current Ratio8.49

Quick Ratio8.49

Book Value/Sh0.48 SEK

Cash/Share0.41 SEK

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 SEK

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.24.29M

Float341.16M

Insiders36.46%

Institutions16.09%

Technical

SMA 504.444 (-61.3%)

SMA 2004.444 (-61.3%)

Beta0.11

S&P 52W Chg14.69%

Avg Vol (30d)40.66K

Avg Vol (10d)2.08K

Technical Indicators

RSI (14)41.9

MACD-0.0255

MACD Signal-0.0111

MACD Hist.-0.0145

BB Upper2.075 SEK

BB Middle1.830 SEK

BB Lower1.584 SEK

BB Width26.83%

ATR (14)0.0897 SEK

Vol Ratio (20d)0.58x